1998 jules gonin lecture of the retina research foundation. Drug treatment of ocular neovascularization and proliferation

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 237, Issue 6, 1999, Pages 445-447

  Wiedemann, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; ANGIOGENESIS INHIBITOR; CYCLO(RGDFV) PEPTIDE; DAUNORUBICIN; DISINTEGRIN; FLUOROURACIL; HEPARIN; RETINOIC ACID; STEROID; UNCLASSIFIED DRUG; VERAPAMIL;

EYE DISEASE; EYE SURGERY; HUMAN; OPERATION DURATION; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; REOPERATION; RETINA MACULA DEGENERATION; SHORT SURVEY; VITRECTOMY;

CALCIUM CHANNEL BLOCKERS; CELL ADHESION; CELL MOVEMENT; CELL SURVIVAL; DAUNORUBICIN; HUMANS; IMMUNOTOXINS; INTEGRINS; MULTICENTER STUDIES; PEPTIDES, CYCLIC; PIGMENT EPITHELIUM OF EYE; RETINAL NEOVASCULARIZATION; TRIAZOLES; VITREORETINOPATHY, PROLIFERATIVE;

EID: 0033019875     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050259     Document Type: Short Survey

References (18)

1. Aylward G (1997) The PVR Study Group: combination adjuvant therapy to surgery for proliferative vitreoretinopathy (personal communication)
2. Campochiaro PA (1997) Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 115:237-241
3. Casey R, Li W (1997) Factors controlling ocular angiogenesis. Am J Ophthalmol 124:521-529
4. Faude F, Reichenbach A, Wiedemann P (1999) A "detachment infusion" for macular translocation surgery. Retina (in press)
5. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25
6. Hammes H, Brownlee M, Jonczyk A, Sutter A, Preissner K (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2:529-533
7. Hanahan D (1997) Signaling vascular morphogenesis and maintenance. Science 277:48-50
8. Heimann K (1998) Workshop on macular translocation, Cologne, Germany
9. Hoffmann S, Gopalakrishna R, Gundimeda U, Murata T, Spee C, Ryan S, Hinton D (1998) Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells. Exp Eye Res 67:45-52
10. Hoffmann S, He S, Ling M (1999) A cyclic integrin antagonist modulates attachment, migration and invasion of RPE cells. ARVO abstract no. 4132. Invest Ophthalmol Vis Sci (in press)
11. Hoffmann S, He S, Ya J, Gill P, Murata T, Spee C, Wiedemann P, Ryan S, Hinton D (1998) TGF-β2 induces expression of Flt-1 in RPE cells and enhances their sensitivity to a VEGF conjugated toxin. Invest Ophthalmol Vis Sci 39:S864
12. Kohn EC, Figg WD, Sarosy GA, Bauer KS, Davis PA, Soltis MJ, Thompkins A, Liotta LA, Reed E (1997) Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations. J Clin Oncol 15:1985-1993
13. Kon C, Occleston N, Charteris D, Daniels J, Aylward G, Khaw P (1998) A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 39:1524-1529
14. Machemer R, Steinhorst UH (1993) Retinal separation, retinotomy, and macular relocation. II. A surgical approach for age-related macular degeneration? Graefe's Arch Clin Exp Ophthalmol 231:635-641
15. Marmor M (1993) Mechanisms of retinal adhesion. Prog Ret Res 12:179-204
16. Preissner K, Kanse S, Hammes H (1997) Integrin chatter and vascular function in diabetic retinopathy. Horm Metab Res 29:643-645
17. Thomas K (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603-606
18. Wiedemann P, Hilgers R, Bauer P, Heimann K (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Am J Ophthalmol 26:550-559